Cantor Fitzgerald reaffirmed its Overweight rating on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) with a consistent price target of $480.00. According to InvestingPro data, Vertex, a prominent ...

Cantor Fitzgerald adjusted its outlook on Amgen shares (NASDAQ:AMGN), reducing the price target from the previous $405.00 to $340.00. Despite the lowered price target, the firm maintained its ...

Cantor Fitzgerald reiterated its Overweight rating and a $480.00 price target for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), which currently trades at $438.40 with a market capitalization of ...

Olivia Rodrigo and Gracie Abrams are rising style stars in their own right, and their latest looks followed in the footsteps of a bonafide fashion icon. On Thursday evening, both singers performed ...

Vertex Pharmaceuticals (VRTX – Research Report) received a Buy rating and a $480.00 price target from Cantor Fitzgerald analyst Olivia Brayer ...

On Friday, Cantor Fitzgerald reaffirmed its Overweight rating on Cipher Mining shares (NASDAQ:CIFR), with a set price target of $11.00. The firm's analyst, Brett Knoblauch, provided insight into ...

Fintel reports that on January 30, 2025, Cantor Fitzgerald upgraded their outlook for Lam Research (WBAG:LRC2) from Neutral to Overweight. There are 1,883 funds or institutions reporting positions ...

Cantor analyst Olivia Brayer she had expected a price tag of $60 to $80 for the pills ahead of the company's own announcement. But she also noted acute pain is often just a 14-day treatment ...

The billionaire tapped to head up President Donald Trump’s Commerce Department has vowed to sell his business holdings within 90 days as he pursues senatorial confirmation. Howard Lutnick ...